Further clinical studies of trimethylpurin-6-ylammonium chloride (NSC-51095) in malignant disease with special emphasis on cancer of urinary bladder.
@inproceedings{Rw1970FurtherCS, title={Further clinical studies of trimethylpurin-6-ylammonium chloride (NSC-51095) in malignant disease with special emphasis on cancer of urinary bladder.}, author={Phillips Rw}, year={1970} }
No Paper Link Available